Relations (1)
related 3.91 — strongly supporting 14 facts
Cognitive Behavioral Therapy is the primary subject of analysis in the systematic review, which evaluates its efficacy across multiple studies regarding symptoms of depression, anxiety, and pain as detailed in [1], [2], and [3]. The review provides specific measurements of CBT's effectiveness compared to treatment as usual, as evidenced by [4], [5], and [6].
Facts (14)
Sources
A systematic review of cognitive behavioral therapy-based ... frontiersin.org 14 facts
claimThe systematic review could not examine whether specific forms of cognitive behavioral therapy (CBT) are more effective than others due to the limited number of randomized controlled trials (RCTs).
measurementIn a systematic review of cognitive behavioral therapy-based interventions, four out of six studies (66%) found significant differences in the reduction of depressive symptoms at follow-up in favor of cognitive behavioral therapy (CBT) compared to treatment as usual (TAU), with effect sizes (d) ranging from 0.75 to 0.26.
referenceThe systematic review examined the efficacy of Cognitive Behavioral Therapy (nine studies), Mindfulness-based Interventions (three studies), Acceptance and Commitment Therapy (one study), and Behavioral Activation Therapy for Depression (one study).
measurementIn the systematic review, all nine studies evaluating Cognitive Behavioral Therapy (CBT) performed baseline comparisons, and all but one study (Boersma et al., 2019) compared CBT with an inactive control group (usual care).
measurementIn the systematic review, five out of nine studies evaluated Cognitive Behavioral Therapy (CBT) as the only therapeutic component, while the remaining four studies evaluated CBT combined with other components.
claimCognitive Behavioral Therapy (CBT)-based interventions for depression or chronic pain show consistent efficacy with previous systematic reviews (Lorenzo-Luaces et al., 2018; López-López et al., 2019; Williams et al., 2020), though the magnitude of the effect is modest.
measurementIn the systematic review, three out of four studies of traditional Cognitive Behavioral Therapy reported significant differences in the reduction of anxiety symptoms at follow-up compared to treatment as usual, with effect sizes (d) ranging from 1.07 to 0.27.
claimThe systematic review organized information from controlled trials according to the type of intervention, specifically Cognitive Behavioral Therapy (CBT), Mindfulness-Based Interventions (MBI), Acceptance and Commitment Therapy (ACT), and Behavioral Activation Treatment for Depression (BATD).
measurementIn a systematic review of cognitive behavioral therapy-based interventions, six out of eight studies (75%) found significant differences in the reduction of depressive symptoms at post-treatment in favor of cognitive behavioral therapy (CBT) compared to treatment as usual (TAU), with effect sizes (d) ranging from 1.31 to 0.18.
measurementIn the systematic review, five out of six studies of traditional Cognitive Behavioral Therapy reported significant differences in the reduction of anxiety symptoms at post-treatment compared to treatment as usual, with effect sizes (d) ranging from 1.08 to 0.19.
claimThe systematic review concludes that traditional Cognitive Behavioral Therapy may produce significant benefits for the improvement of depression, anxiety, and quality of life, but not for pain intensity and pain catastrophizing.
claimThe systematic review found no significant differences between traditional Cognitive Behavioral Therapy and treatment as usual at post-treatment and follow-up regarding pain intensity and pain catastrophizing.
measurementIn the systematic review, four out of six studies of traditional Cognitive Behavioral Therapy reported significant differences in the reduction of depressive symptoms at follow-up compared to treatment as usual, with effect sizes (d) ranging from 0.75 to 0.26.
measurementIn the systematic review, six out of eight studies of traditional Cognitive Behavioral Therapy reported significant differences in the reduction of depressive symptoms at post-treatment compared to treatment as usual, with effect sizes (d) ranging from 1.31 to 0.18.